Rapid Dose Therapeutics Corp. (RDTCF)

USD 0.18

(2150.0%)

Revenue Summary of Rapid Dose Therapeutics Corp.

  • Rapid Dose Therapeutics Corp.'s latest annual revenue in 2024 was 1.02 Million CAD , up 42.06% from previous year.
  • Rapid Dose Therapeutics Corp.'s latest quarterly revenue in 2024 FY was 1.02 Million CAD , up 42.06% from previous quarter.
  • Rapid Dose Therapeutics Corp. reported a annual revenue of 718.29 Thousand CAD in annual revenue 2023, down -59.0% from previous year.
  • Rapid Dose Therapeutics Corp. reported a annual revenue of 1.75 Million CAD in annual revenue 2022, up 566.62% from previous year.
  • Rapid Dose Therapeutics Corp. reported a quarterly revenue of 1.02 Million CAD for 2024 FY, up 42.06% from previous quarter.
  • Rapid Dose Therapeutics Corp. reported a quarterly revenue of 192.65 Thousand CAD for 2024 Q4, down -17.6% from previous quarter.

Annual Revenue Chart of Rapid Dose Therapeutics Corp. (2024 - 2009)

Historical Annual Revenue of Rapid Dose Therapeutics Corp. (2024 - 2009)

Year Revenue Revenue Growth
2024 1.02 Million CAD 42.06%
2023 718.29 Thousand CAD -59.0%
2022 1.75 Million CAD 566.62%
2021 262.8 Thousand CAD 158.93%
2020 101.49 Thousand CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%

Peer Revenue Comparison of Rapid Dose Therapeutics Corp.

Name Revenue Revenue Difference
Bioxytran, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 93.531%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 95.249%
Intellipharmaceutics International Inc. 65.72 Thousand USD -1452.495%
Evofem Biosciences, Inc. 18.21 Million USD 94.399%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.17%
Propanc Biopharma, Inc. - USD -Infinity%
Marizyme, Inc. 645.81 Thousand USD -58.007%
Genus plc 668.8 Million USD 99.847%
Pharming Group N.V. 245.31 Million USD 99.584%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -930.794%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -148.784%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -1229.352%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -2482.175%
ONE Bio Corp. 52.29 Million USD 98.049%
RVL Pharmaceuticals plc 49.72 Million USD 97.948%
Mesoblast Limited 5.9 Million USD 82.711%
MultiCell Technologies, Inc. 49.32 USD -2068886.212%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 29.59 Million USD 96.552%
Genscript Biotech Corporation 839.52 Million USD 99.878%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -5690.954%
Biomind Labs Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -82.967%
Oncotelic Therapeutics, Inc. 70 Thousand USD -1357.749%
Skye Bioscience, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -1247.557%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -54.962%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -1986.757%
Q BioMed Inc. 284.35 Thousand USD -258.859%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.993%
Agentix Corp. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.297%
Enzolytics Inc. 52.79 Thousand USD -1832.768%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -67.688%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.917%
Northwest Biotherapeutics, Inc. 1.93 Million USD 47.183%
HST Global, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -102044.545%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -627.617%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -65.282%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -2.275%
Capstone Therapeutics Corp. 48.35 Million USD 97.89%
Kadimastem Ltd - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 93.884%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -331.359%
Regen BioPharma, Inc. 236.56 Thousand USD -331.359%
Affymax, Inc. 1.36 Million USD 25.462%
Mobile Lads Corp. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 86.899%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -115.402%
SYBLEU INC 11.69 Thousand USD -8624.555%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -7749.415%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -2481.13%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 69.357%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 84.69%
IntelGenx Technologies Corp. 1.03 Million USD 1.788%
Gelesis Holdings, Inc. 25.76 Million USD 96.04%
CSL Limited 14.8 Billion USD 99.993%
Cellectis S.A. 755 Thousand USD -35.155%